As GLP1s boom, dietician startups Berry Street, Fay each nab $50M rounds

Quick Summary:

That changed in recent years with the discovery of Ozempic and other GLP-1 drugs that help people lose weight.

For decades, the US healthcare system has struggled to address the diet-related chronic illnesses affecting nearly half of all adults.

He says that he has been clinically obese since childhood.“I tried everything to combat my poor diet,” he said.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Marina Temkin

Category: StartupsBusiness

Markets: United States

Topics: Fay Ozempic Nutrition Startups Goldman Sachs Northzone

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-02-05 @ 19:30:00 (17 hours ago)

News Timezone: GMT -5:00

News Source URL: techcrunch.com

Language: English

Article Length: 616 words

Reading Time: 4 minutes read

Sentences: 25 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © TechCrunch

News ID: 25915129

View Article Analysis

About TechCrunch

Main Topics: StartupsBusiness

Official Website: techcrunch.com

Update Frequency: 1 posts per day

Year Established: 2005

Headquarters: United States

News Last Updated: 1 weeks ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #4

Publisher Details

Frequently Asked Questions